Stock Talk – April, 2016

Stock Talk

Jim Pearce

Jim Pearce

For those of you following Argos (ARGS), the company recently published a presentation that summarizes the status of their various trials, along with operating results: http://files.shareholder.com/downloads/AMDA-TSH5S/1552720206x0x885796/818E8669-CF5F-4DA4-839C-028872B19156/ARGS_IR_Slide_Deck_April_2016.pdf.

Jim Pearce

Jim Pearce

Also, please see this Alert (http://www.investingdaily.com/breakthrough-tech-profits/alerts/) for my thoughts on the company’s recent announcement regarding the departure of its COO and related actions.

Santosh Reddy

Santosh Reddy

Args stock is at 725/share and the support level is at 4.90. Is it advisible to wait till it drops or enter at
current price before april 30th ? Thanks

Santosh

Jim Pearce

Jim Pearce

Hi Santosh. Tomorrow’s issue of BTP will include an update on our current opinion of ARGS. As we stated in last week’s Alert, we think the market may be misinterpreting last week’s announcement in which case buying on weakness makes sense. However, you are correct that the current price is still far above its support level so let’s see what happens this week. And keep in mind April 30 is the earliest date the company might release interim test results, and could be as late as the end of May so don’t rush back into it.

Add New Comments

You must be logged in to post to Stock Talk OR create an account